Results 281 to 290 of about 104,861 (298)

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency

Cancer Cell, 2018
Chaoyang Sun, Jun Yin, Jian Chen
exaly  

PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applications

Drug Resistance Updates, 2009
Yvette Drew, Ruth Plummer
exaly  

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

PARP Inhibitors

2006
openaire   +1 more source

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

Cancer Cell, 2019
Daniel J McGrail, Chaoyang Sun, Marilyne Labrie   +2 more
exaly  

<p>PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives</p>

Cancer Management and Research, 2020
Lucia Musacchio, Giuseppe Caruso, Daniela Russo   +2 more
exaly  

Synthetic inhibitors - PARP inhibitors

2020
openaire   +1 more source

PARP inhibitors: Clinical utility and possibilities of overcoming resistance

Gynecologic Oncology, 2017
Zachary L Watson, Kian Behbakht, Benjamin G Bitler   +2 more
exaly  

PARP Inhibitors

2017
openaire   +1 more source

Making the best of PARP inhibitors in ovarian cancer

Nature Reviews Clinical Oncology, 2010
Susana Banerjee, Alan Ashworth
exaly